ArticleFrontiers in pharmacology2025

Ivarmacitinib improves patient-reported outcomes across multiple domains in patients with active ankylosing spondylitis: a

Xiaoyan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.